CopyMark Law Group
4.9/5
Drawing for SEA4US

USPTO serial 79335488

SEA4US

Reviewed by CopyMark Law Group

Reg. 6976431Status 700Registered
Filing date
Status date
Registration date
Feb 14, 2023
Examiner
JOHNSON, AISHA CLARKE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SEA4US?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elizabeth Lee D'Amore

Elizabeth Lee D'Amore Lucas & Mercanti, LLP100 S. Jefferson Road, Suite 202Whippany, NJ 07981United States

Goods and services

ClassDescriptionStatusFirst use
005Extracts of seaweed, cultures of microorganisms, cultures of invertebrates, plants and herbs extracts, by-products of the processing of plants, herbs, seaweed, microorganisms and invertebrates, substances, drug delivery compounds, preparations and drugs for medical, veterinary or pharmaceutical purposes; nutritional, food and mineral supplements; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, urologic, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, central nervous system, peripheral nervous system and immune system related diseases and disorders ; Chemical and chemico-pharmaceutical preparations for pharmaceutical or medical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, urologic, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, central nervous system, peripheral nervous system and immune system related diseases and disorders; Nutraceutical for use as a dietary supplement; biocidal and disinfectant products, for medical, veterinary, medicinal, therapeutical, pharmaceutical, and nutritional purposesACTIVE—
042Scientific and laboratory research and analysis in the field of biotechnology, microbiology, pharmacology, physiology, chemistry, biochemistry, electrochemistry, bioinformatics, molecular biology, cell biology, cell cultures, animal models, clinical trials, pharmaceutical research, cosmetic, medicine, marine biology, aquaculture and marine resource explorationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 9, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 9, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 9, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 9, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 4, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 17, 2023XXSSGENERIC MADRID TRANSACTION SENT TO IB—
May 17, 2023XXCRGENERIC MADRID TRANSACTION CREATED—
May 14, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 14, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 14, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 13, 2022GPNXNOTIFICATION PROCESSED BY IB—
Nov 29, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 29, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 23, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 23, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 9, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 24, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 21, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 21, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 21, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 2, 2022RFNTREFUSAL PROCESSED BY IB—
Jul 8, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 8, 2022RFRRREFUSAL PROCESSED BY MPU—
Jul 8, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 7, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2022DOCKASSIGNED TO EXAMINER—
Mar 15, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 11, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 10, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance